Acadia Pharmaceuticals (ACAD) Change in Inventory (2016 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Change in Inventory of -$78000.0 for Q1 2026, down 100.75% year-over-year from $10.5 million in Q1 2025, and down 101.59% quarter-over-quarter from $4.9 million in Q4 2025.
Acadia Pharmaceuticals (ACAD) Change in Inventory (2016 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Change in Inventory history runs 11 years deep, the most recent figure standing at -$78000.0 for Q1 2026.
- In Q1 2026, Change in Inventory fell 100.75% year-over-year to -$78000.0; the TTM figure through Mar 2026 stood at $7.7 million (down 82.32% YoY), while the FY2025 annual figure was $18.2 million, down 63.28% from the prior year.
- Change in Inventory for Q1 2026 stood at -$78000.0, down from $4.9 million in the prior quarter.
- The five-year high for Change in Inventory was $27.1 million in Q2 2024, with the low at -$1.2 million in Q3 2025.
- The 5-year median for Change in Inventory is $3.0 million (2023), against an average of $5.5 million.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory tumbled 269.31% in 2022, then surged 4960.32% in 2023.
- Acadia Pharmaceuticals' Change in Inventory stood at -$310000.0 in 2022, then soared by 4960.32% to $15.1 million in 2023, then sank by 70.64% to $4.4 million in 2024, then grew by 10.58% to $4.9 million in 2025, then slumped by 101.59% to -$78000.0 in 2026.
- Business Quant data shows ACAD's Change in Inventory at -$78000.0 in Q1 2026, $4.9 million in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.90 Mn |
| Jun 30, 2026 | -3.90 Mn |
| Mar 31, 2026 | -78,000.00 |
| Mar 31, 2026 | -78,000.00 |
| Dec 31, 2025 | 4.89 Mn |
| Dec 31, 2025 | 4.89 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 10.45 Mn |
| Mar 31, 2025 | 10.45 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 27.15 Mn |
| Jun 30, 2024 | 27.15 Mn |
| Mar 31, 2024 | 16.65 Mn |
| Mar 31, 2024 | 16.65 Mn |